Scientific Progress

Thanks to the rapid progress in science over the course of the last decades we are able to offer our ambitious products to customers worldwide.

TICEBA - Company - Scientific Progress - Picture 01TICEBA - Company - Scientific Progress - Picture 02


The 21st century will be a century of biology and medicine. Tissue engineering (reconstruction of tissue) will be one of the key technologies. This still fledgling branch of medicine is among others dealing with the reproduction of tissue and whole organs from adult stem cells.

These adult stem cells have a decisive repair function. They are able to replace defective cells and allow for the organ or cell structure to be able to again carry out its original function.

Tissue engineering aims at "repairing" body tissue and organs with the help of adult stem cells and to thereby re-establish their natural function or to maintain it over longer time periods than ever before.

It is TICEBA's aim to offer its customers the possibility to retrieve their own healthy stem cells whenever they are needed for this kind of healing process.

Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcers (CVU), diabetic foot ulcers (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.


Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.